ATOMOXETIN Mepha caps 40 mg 7 pce

7680675880065 CH-67588 N06BA09 01.10.2.

Reimbursement limitations:

STRATTERA

Pour le traitement de deuxième ligne du trouble déficitaire de l'attention avec hyperactivité (TDAH), lors …

ATOMOXETIN Mepha caps 40 mg 7 pce
ATOMOXETIN Mepha caps 40 mg 7 pce
ATOMOXETIN Mepha caps 40 mg 7 pce
1 / 3
google

Details

Product number
6758804
CPT
-
Packaging group
7
Unit
Kapsel(n)
Composition
atomoxetinum 40 mg corresp. atomoxetini hydrochloridum 45.72 mg, maydis amylum, amylum pregelificatum, dimeticonum 350, carboxymethylamylum natricum A, Kapselhülle: gelatina, E 132, E 171, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 1.01 mg.

Articles (1)

Atomoxetin-Mepha 40 mg, Hartkapseln
Kapseln
7
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/03/2025
Patient information leaflet
Français
06/03/2025
Patient information leaflet
Italien
06/03/2025
Professional SmPC
Allemand
06/03/2025
Professional SmPC
Français
06/03/2025
Professional SmPC
Italien
06/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
45.72 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
1.01 MG Substance HBESI

Reimbursement information

Public price
CHF 17.85
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2021

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67588
Drug name
Atomoxetin-Mepha, Hartkapseln
Galenic form
KAHA
ATC Code
N06BA09
Authorization status
Z
Dispensation category
A
First authorization
16/01/2020
Authorization expiration date
31/12/9999
IT number
01.10.2.
Domain
Human medicine
Field of application
Zentral wirksames Sympathomimetikum, nicht stimulierend

Packaging details

Description (FR)
ATOMOXETIN Mepha caps 40 mg 7 pce
Description (DE)
ATOMOXETIN Mepha Kaps 40 mg 7 Stk
Market launch
16/01/2020
Narcotic (BTM)
No

Other packaging sizes

ATOMOXETIN Mepha caps 10 mg 7 pce
7 KAP
View
ATOMOXETIN Mepha caps 18 mg 7 pce
7 KAP
View
ATOMOXETIN Mepha caps 18 mg 28 pce
28 KAP
View
ATOMOXETIN Mepha caps 25 mg 7 pce
7 KAP
View
ATOMOXETIN Mepha caps 25 mg 28 pce
28 KAP
View
ATOMOXETIN Mepha caps 40 mg 28 pce
28 KAP
View
ATOMOXETIN Mepha caps 60 mg 28 pce
28 KAP
View
ATOMOXETIN Mepha caps 80 mg 28 pce
28 KAP
View
ATOMOXETIN Mepha caps 100 mg 28 pce
28 KAP
View